C C Bancroft
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways
Papers in
-
- NF-κB Signaling Pathways 3
-
- Angiogenesis and VEGF in Cancer 1
- Ubiquitin and proteasome pathways 1
- Co-authors
- Ning T. Yeh (5 shared papers)John B. Sunwoo (4 shared papers)Carter Van Waes (4 shared papers)Zhong Chen (3 shared papers)Guo‐Chung Dong (2 shared papers)Zhong Chen (2 shared papers)Carter Van Waes (2 shared papers)Edward A. Sausville (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)PubMed (4 papers)
- Partner nations
- United States
In The Last Decade
C C Bancroft
6 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 374
- Oncology 450
- Hepatology 102
- Molecular Biology 695
- Immunology 186
Countries citing papers authored by C C Bancroft
This map shows the geographic impact of C C Bancroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C C Bancroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C C Bancroft more than expected).
Fields of papers citing papers by C C Bancroft
This network shows the impact of papers produced by C C Bancroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C C Bancroft. The network helps show where C C Bancroft may publish in the future.
Co-authors
The 19 scholars most cited alongside C C Bancroft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. | 2001 | 426 |
| 2 | Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. | 2001 | 237 |
| 3 | 2002 | 210 | |
| 4 | IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. | 2001 | 197 |
| 5 | Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. | 2001 | 166 |
| 6 | 2000 | 30 |
About C C Bancroft
C C Bancroft is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Pathology and Forensic Medicine, having authored 6 papers that have together received 1.3k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Immune Response and Inflammation (2 papers), Cancer Mechanisms and Therapy (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Ubiquitin and proteasome pathways (1 paper), Immunotherapy and Immune Responses (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Cancer Research (374 citations), Oncology (450 citations), Hepatology (102 citations), Molecular Biology (695 citations) and Immunology (186 citations). C C Bancroft has collaborated with scholars based in United States. Frequent co-authors include Ning T. Yeh, John B. Sunwoo, Carter Van Waes, Zhong Chen, Guo‐Chung Dong, Zhong Chen, Carter Van Waes, Edward A. Sausville, Peter J. Elliott and Julian Adams. Their work appears in journals such as International Journal of Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.